Use of bacteriophages in the treatment of colistin-only-sensitive Pseudomonas aeruginosa septicaemia in a patient with acute kidney injury-a case report

Critical Care

Volumn 21, Issue 1, 2017, Pages

  Jennes, Serge ^a   Merabishvili, Maia ^a   Soentjens, Patrick ^a   Pang, Kim Win ^a   Rose, Thomas ^a   Keersebilck, Elkana ^a   Soete, Olivier ^a   François, Pierre Michel ^a   Teodorescu, Simona ^a   Verween, Gunther ^a   Verbeken, Gilbert ^a   De Vos, Daniel ^a   Pirnay, Jean Paul ^a  

^a QUEEN ASTRID MILITARY HOSPITAL   (Belgium)

Author keywords

Acute kidney injury; Antibiotic resistance; Bacteraemia; Bacteriophage therapy; Colistin; Intravenous; Pseudomonas aeruginosa

Indexed keywords

C REACTIVE PROTEIN; COLISTIN; CREATININE; UREA; ANTIINFECTIVE AGENT;

ACUTE KIDNEY FAILURE; ADULT; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BACTERIAL PERITONITIS; CASE REPORT; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DECUBITUS; DIAPHRAGM HERNIA; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTION; GANGRENE; HUMAN; INTESTINE OBSTRUCTION; LEG AMPUTATION; LETTER; MALE; MIDDLE AGED; NONHUMAN; PHAGE THERAPY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SEPSIS; SEPTICEMIA; UREA BLOOD LEVEL; BACTERIOPHAGE; COMPLICATION; PATHOGENICITY;

ACUTE KIDNEY INJURY; ANTI-BACTERIAL AGENTS; BACTERIOPHAGES; COLISTIN; HUMANS; MALE; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SEPSIS;

EID: 85020212842     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/s13054-017-1709-y     Document Type: Letter

References (3)

1. World Medical Association. Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. JAMA. 2013;310:2191-4.
2. Merabishvili M, Pirnay JP, Verbeken G, Chanishvili N, Tediashvili M, Lashkhi N, et al. Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials. PLoS One. 2009;4:e4944.
3. Speck P, Smithyman A. Safety and efficacy of phage therapy via the intravenous route. FEMS Microbiol Lett. 2016;363:fnv242.